Our Divisions

Three specialized divisions: API Development, Formulation Solutions, and R&D Contract Services

Overview

Acute Research is an R&D-driven company with three specialized divisions. We provide turnkey support from lab to commercial batches, with documentation packages and regulatory support ready for submissions. Our experience includes handling sterile injectable APIs with tight internal specifications.

API Division — Overview

We are an R&D-driven company with a strong QA culture. We specialise in niche, high-value APIs with full regulatory and plant support for customers who demand stringent specs and sterile-use readiness.

Production Facility

EU-GMP capable facility with dedicated suites for sterile-use APIs, validated processes, robust stability programs and full documentation packages (DMF / CTD / batch records) for regulated markets.

Product Snapshot

Molecule Category Documentation Status

Why partner with Acute

  • Turnkey support from lab to commercial batches.
  • Documentation packages and regulatory support ready for submissions.
  • Experience handling sterile injectable APIs and tight internal specs.
  • Niche, high-value APIs with full regulatory and plant support.

Formulation Division

Focused portfolio of sterile injectables and topical formulations — lyophilization expertise for stable parenteral presentations and topical wound-care solutions.

Selected Products

  • Tigecycline — Sterile lyophilized powder for IV infusion (50 mg/vial, single-dose)
  • Naftifine HCl — Topical 1% and 2% cream/gel (15g–90g tubes)
  • Feracrylum — Gel 1% & 3% and 1% sterile antiseptic solution for wound care

Capabilities

  • Lyophilization cycle development and optimization
  • Sterile injectable formulation development
  • Topical formulation expertise
  • Small clinical batch support

R&D & Contract Services

State-of-the-art analytical and process R&D labs. Flexible FTF / FFS / lab-on-rent models with pilot scale and method validation services. Our R&D suites support bench and small pilot-scale process development, analytical method development, formulation lab work and lyophilization cycle development.

Core R&D Capabilities

  • Benchtop process development — glass and small stainless reactors for reaction scouting and optimization
  • Formulation lab — excipient screening, stability screening, lyophilization cycle development
  • Analytical & method development — HPLC/UHPLC, GC, FTIR, UV-Vis and method validation
  • Pilot utilities — pilot lyophilizer access, small-scale filtration and centrifugation

How R&D supports your project

  • End-to-end development: reaction optimisation → impurity profile resolution → analytical method & stability testing
  • Lyophilization cycle development, vial fill optimisation and small clinical batch support
  • Method transfer and tech-transfer packages ready for pilot / commercial scale-up

Acute Chemtech

Acute Chemtech is our manufacturing & scale-up vertical. For commercial-scale operations and purchase enquiries please contact the team.

Facility Highlights

  • EU-GMP capable suites
  • Lyophilization & sterile fill expertise
  • Analytical method development & stability labs
  • Regulatory documentation & DMF support